• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VLS
Click for more information
0.00% $2.22

VITA LIFE SCIENCES LIMITED.. - Corporate Spotlight

Market Cap $125.2M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Vita Life Sciences Limited (Vita Life) is a pharmaceutical and healthcare company. The... Vita Life Sciences Limited (Vita Life) is a pharmaceutical and healthcare company. The Company is involved in formulating, packaging, sales and distributing vitamins and supplements. Its core business is the development and distribution of over-the-counter (OTC) medicines, as well as complementary and alternative medicines, dietary supplements and health foods under various brand names throughout Australia, Malaysia, Singapore, Thailand, Vietnam, China and Indonesia. Its brand portfolio includes Herbs of Gold, VitaHealth, VitaScience and VitaLife. Herbs of Gold brand produces premium herbal, mineral, vitamin and superfood products. VitaHealth brand offers a comprehensive range of nutritional products that cater to every health need, from inner wellness to outer radiance. VitaScience is a vivacious nutritional supplement brand that offers practitioner strength quality formulations. Its subsidiaries include Vita Healthcare Asia Pacific Sdn Bhd, Herbs of Gold Sdn Bhd and others.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
$2.22 		Change
0.000(0.00%) 		Mkt cap ! $125.2M
Open High Low Value Volume
$2.22 $2.22 $2.22 $2 1

Buyers (Bids)

No. Vol. Price($)
1 1951 $2.22
 

Sellers (Offers)

Price($) Vol. No.
$2.23 2 1
View Market Depth
Last trade - 10.09am 03/10/2024 (20 minute delay) ?
VLS (ASX) Chart

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20% Chariot has unveiled its vision for its US-based Black Mountain – aiming to fast-track its path to production by establishing a "pilot mine."
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Firefly positioned for copper growth in Canada ahead of resource update Firefly Metals Ltd has reported drilling reports from its Green Bay copper-gold project in Newfoundland, ahead of a resource update
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.